New diabetes clinical trial: Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study
Published on: 2026-04-03T04:00:00Z
Conditions: Methamphetamine Use Disorder
Interventions: Drug: 12 weeks of weekly subcutaneous semaglutide injection
Sponsors: Kirby Institute
Not yet recruiting
https://ift.tt/JnTwVHv
Conditions: Methamphetamine Use Disorder
Interventions: Drug: 12 weeks of weekly subcutaneous semaglutide injection
Sponsors: Kirby Institute
Not yet recruiting
https://ift.tt/JnTwVHv
Comments
Post a Comment